165 related articles for article (PubMed ID: 37466425)
1. Use of antibiotics in hospitalized patients with COVID-19: evolving concepts in a highly dynamic antimicrobial stewardship scenario.
Bassetti M; Brucci G; Vena A; Giacobbe DR
Expert Opin Pharmacother; 2023; 24(15):1679-1684. PubMed ID: 37466425
[TBL] [Abstract][Full Text] [Related]
2. Bacterial co-infection and antibiotic stewardship in patients with COVID-19: a systematic review and meta-analysis.
Calderon M; Gysin G; Gujjar A; McMaster A; King L; Comandé D; Hunter E; Payne B
BMC Infect Dis; 2023 Jan; 23(1):14. PubMed ID: 36624396
[TBL] [Abstract][Full Text] [Related]
3. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship.
Rothe K; Feihl S; Schneider J; Wallnöfer F; Wurst M; Lukas M; Treiber M; Lahmer T; Heim M; Dommasch M; Waschulzik B; Zink A; Querbach C; Busch DH; Schmid RM; Schneider G; Spinner CD
Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):859-869. PubMed ID: 33140176
[TBL] [Abstract][Full Text] [Related]
4. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.
Karami Z; Knoop BT; Dofferhoff ASM; Blaauw MJT; Janssen NA; van Apeldoorn M; Kerckhoffs APM; van de Maat JS; Hoogerwerf JJ; Ten Oever J
Infect Dis (Lond); 2021 Feb; 53(2):102-110. PubMed ID: 33103530
[TBL] [Abstract][Full Text] [Related]
5. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.
Rawson TM; Moore LSP; Zhu N; Ranganathan N; Skolimowska K; Gilchrist M; Satta G; Cooke G; Holmes A
Clin Infect Dis; 2020 Dec; 71(9):2459-2468. PubMed ID: 32358954
[TBL] [Abstract][Full Text] [Related]
6. The experience of an antimicrobial stewardship program and antibiotic consumption and resistance trends during the COVID-19 pandemic at a tertiary care center in Beirut.
Haddad N; Zeenny RM; El Halabi C; Abdallah T; El Helou R; Zahreddine NK; Kanj SS; Rizk NA
J Infect Public Health; 2024 Feb; 17(2):254-262. PubMed ID: 38128409
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial use in patients with confirmed COVID-19 infection in the Philippines: a cross-sectional study.
Dominguez RJ; Domingo-Cereno NA; Josue-Dominguez RT
Western Pac Surveill Response J; 2023; 14(2):1-8. PubMed ID: 37475781
[TBL] [Abstract][Full Text] [Related]
8. Co-infections and antimicrobial use among hospitalized COVID-19 patients in Punjab, Pakistan: findings from a multicenter, point prevalence survey.
Mustafa ZU; Saleem MS; Ikram MN; Salman M; Butt SA; Khan S; Godman B; Seaton RA
Pathog Glob Health; 2022 Oct; 116(7):421-427. PubMed ID: 34783630
[TBL] [Abstract][Full Text] [Related]
9. A point prevalence survey to assess antibiotic prescribing in patients hospitalized with confirmed and suspected coronavirus disease 2019 (COVID-19).
Tan SH; Ng TM; Tay HL; Yap MY; Heng ST; Loo AYX; Teng CB; Lee TH
J Glob Antimicrob Resist; 2021 Mar; 24():45-47. PubMed ID: 33307276
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysis.
Alshaikh FS; Godman B; Sindi ON; Seaton RA; Kurdi A
PLoS One; 2022; 17(8):e0272375. PubMed ID: 35913964
[TBL] [Abstract][Full Text] [Related]
11. Could the COVID-19 pandemic aggravate antimicrobial resistance?
Rossato L; Negrão FJ; Simionatto S
Am J Infect Control; 2020 Sep; 48(9):1129-1130. PubMed ID: 32603851
[No Abstract] [Full Text] [Related]
12. Bacterial co-infections, secondary infections and antimicrobial use among hospitalized COVID-19 patients in the sixth wave in Pakistan: findings and implications.
Ul Mustafa Z; Batool A; Ibrar H; Salman M; Khan YH; Mallhi TH; Meyer JC; Godman B; Moore CE
Expert Rev Anti Infect Ther; 2024 Apr; 22(4):229-240. PubMed ID: 38146949
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial Stewardship in a Pandemic: Picking Up the Pieces.
Furukawa D; Graber CJ
Clin Infect Dis; 2021 May; 72(10):e542-e544. PubMed ID: 32857832
[No Abstract] [Full Text] [Related]
14. Suboptimal antimicrobial stewardship in the COVID-19 era: is humanity staring at a postantibiotic future?
Owoicho O; Tapela K; Djomkam Zune AL; Nghochuzie NN; Isawumi A; Mosi L
Future Microbiol; 2021 Aug; 16():919-925. PubMed ID: 34319168
[TBL] [Abstract][Full Text] [Related]
15. Increased antimicrobial resistance during the COVID-19 pandemic.
Lai CC; Chen SY; Ko WC; Hsueh PR
Int J Antimicrob Agents; 2021 Apr; 57(4):106324. PubMed ID: 33746045
[TBL] [Abstract][Full Text] [Related]
16. Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study.
Coenen S; de la Court JR; Buis DTP; Meijboom LJ; Schade RP; Visser CE; van Hest R; Kuijvenhoven M; Prins JM; Nijman SFM; Sieswerda E; Sigaloff KCE
Antimicrob Resist Infect Control; 2021 Oct; 10(1):155. PubMed ID: 34717761
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis.
Langford BJ; So M; Raybardhan S; Leung V; Soucy JR; Westwood D; Daneman N; MacFadden DR
Clin Microbiol Infect; 2021 Apr; 27(4):520-531. PubMed ID: 33418017
[TBL] [Abstract][Full Text] [Related]
18. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.
Chong WH; Saha BK; Ananthakrishnan Ramani ; Chopra A
Infection; 2021 Aug; 49(4):591-605. PubMed ID: 33709380
[TBL] [Abstract][Full Text] [Related]
19. Bacterial coinfections in COVID-19: an underestimated adversary.
Fattorini L; Creti R; Palma C; Pantosti A; ;
Ann Ist Super Sanita; 2020; 56(3):359-364. PubMed ID: 32959802
[TBL] [Abstract][Full Text] [Related]
20. Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings.
Lucien MAB; Canarie MF; Kilgore PE; Jean-Denis G; Fénélon N; Pierre M; Cerpa M; Joseph GA; Maki G; Zervos MJ; Dely P; Boncy J; Sati H; Rio AD; Ramon-Pardo P
Int J Infect Dis; 2021 Mar; 104():250-254. PubMed ID: 33434666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
